x

Search for an orphan drug

* (*) mandatory field

Other search option(s)

Tecentriq

Atezolizumab   

    • Marketing authorisation without orphan designation  - Europe

    • Diseases list
      • Upper tract urothelial carcinoma
      • Non-papillary transitional cell carcinoma of the bladder
    • Detailed information

    • Marketing authorisation without orphan designation  - Europe

    • Diseases list
      • Small cell lung cancer
      • Adult hepatocellular carcinoma
    • Detailed information

    • Marketing authorisation with orphan designation  - USA

    • Diseases list
      • Small cell lung cancer
    • Detailed information

    • Marketing authorisation with orphan designation  - USA

    • Diseases list
      • NON RARE IN EUROPE: Melanoma
    • Detailed information

    • Marketing authorisation with orphan designation  - USA

    • Diseases list
      • Hepatocellular carcinoma
    • Detailed information

    • Marketing authorisation with orphan designation  - USA

    • Diseases list
      • Alveolar soft tissue sarcoma
    • Detailed information

Additional information

Research on this medical product

Appraisal/reimbursement

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.